Detalhe da pesquisa
1.
Cancer patients have a reduced likelihood of dying in hospital with advance care planning in primary health care and a summarizing palliative plan: a prospective controlled non-randomized intervention trial.
Scand J Prim Health Care
; : 1-12, 2024 Apr 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-38662520
2.
Cancer patients spend more time at home and more often die at home with advance care planning conversations in primary health care: a retrospective observational cohort study.
BMC Palliat Care
; 21(1): 61, 2022 May 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-35501797
3.
Spiritual quality of life in family carers of patients with advanced cancer-a cross-sectional study.
Support Care Cancer
; 29(9): 5329-5339, 2021 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-33661369
4.
A qualitative study of bereaved family caregivers: feeling of security, facilitators and barriers for rural home care and death for persons with advanced cancer.
BMC Palliat Care
; 20(1): 7, 2021 Jan 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-33419428
5.
Resilience for family carers of advanced cancer patients-how can health care providers contribute? A qualitative interview study with carers.
Palliat Med
; 32(8): 1410-1418, 2018 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-29852808
6.
Palliative treatment of patients with COVID-19. / Palliativ behandling av pasienter med covid-19.
Tidsskr Nor Laegeforen
; 140(7)2020 05 05.
Artigo
em Nor
| MEDLINE | ID: mdl-32378853
7.
Standardizing Integrated Oncology and Palliative Care Across Service Levels: Challenges in Demonstrating Effects in a Prospective Controlled Intervention Trial.
Oncol Ther
; 2024 May 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-38744750
8.
Implementing a Standardized Care Pathway Integrating Oncology, Palliative Care and Community Care in a Rural Region of Mid-Norway.
Oncol Ther
; 9(2): 671-693, 2021 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-34731447
9.
Fully Integrated Oncology and Palliative Care Services at a Local Hospital in Mid-Norway: Development and Operation of an Innovative Care Delivery Model.
Pain Ther
; 9(1): 297-318, 2020 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-32274655
10.
FGFR3 is expressed and is important for survival in INA-6, a human myeloma cell line without a t(4;14).
Eur J Haematol
; 83(5): 471-6, 2009 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-19594619
11.
High expression of BCL3 in human myeloma cells is associated with increased proliferation and inferior prognosis.
Eur J Haematol
; 82(5): 354-63, 2009 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-19191868
12.
Bone morphogenetic protein-5, -6 and -7 inhibit growth and induce apoptosis in human myeloma cells.
Oncogene
; 23(17): 3024-32, 2004 Apr 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-14691444
13.
A low serum level of soluble tumor necrosis factor receptor p55 predicts response to thalidomide in advanced multiple myeloma.
Haematologica
; 89(5): 552-6, 2004 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-15136218
14.
Osteopontin is an adhesive factor for myeloma cells and is found in increased levels in plasma from patients with multiple myeloma.
Haematologica
; 89(2): 174-82, 2004 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-15003892
15.
Interleukin-21 is a growth and survival factor for human myeloma cells.
Blood
; 99(10): 3756-62, 2002 May 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-11986233